FAIRFIELD, Iowa, April 18, 2016 – Hedge funds gained 2.53% in March, its best month since January 2012 when it rose 3.10%, according to the Barclay Hedge Fund Index compiled by BarclayHedge. The Index is down 0.88% after three months in 2016.
“Rebounding oil prices and dovish central bank policy and statements helped propel mid-February’s equity and high yield rally into March,” says Sol Waksman, founder and president of BarclayHedge.
Overall, 15 of Barclay’s 18 hedge fund indices were profitable in March. The Emerging Markets Index led the way with its 5.06% gain, Event Driven rose 3.58%, Equity Long Bias increased 3.51%, and the Technology Index was up 3.19%.
On the negative side, the Equity Short Bias Index lost 4.35% in March, European Equities dropped 0.94% and Global Macro declined 0.30%.
After three months in 2016, all but four indices continue in the loss column. The Healthcare and Biotechnology Index has dropped 10.46%, the European Equities Index is down 5.47%, Equity Long Bias has lost 2.48%, and Pacific Rim Equities have declined 2.35%.
The Barclay Fund of Funds Index gained 0.54% in March, and has lost 3.21% year to date.
Click here to view five years of Barclay Hedge Fund Index data, or to download 19 years of monthly data.
Sol Waksman is an experienced media source, providing perspectives on hedge fund and managed futures trends. For more commentary or background, call 641-472-3456 or email swaksman@barclayhedge.com.
BarclayHedge is the global leader in providing independent, research-based information services to the alternative investment industry. Founded in 1985, Barclay currently maintains data on more than 6,300 hedge funds, fund of funds, and CTAs. No one has been in the business of collecting alternative investment data longer than BarclayHedge.
Institutional investors, brokerage firms, and private banks worldwide utilize BarclayHedge indices as performance benchmarks for the hedge fund and managed futures industries.